Similarly, HCV infection upregulates SLC1A5 to drive glutamine addiction in cancer cells [43], and a recent study demonstrated that SLC1A5 membrane localization increases the presence of hACE2 receptors able to bind the SARS-CoV-2-RBD [48]. The gene discussed is SLC1A5; the disease is cancer.